Emerging Treatments
for Type 2 Diabetes:

Focus on Incretin Therapies

New and Emerging Treatment Options in Type 2 Diabetes

Activity Overview

Please read the following information about this continuing education activity before accessing the presentation using the link located at the bottom of this page.

Release Date: February 1, 2014 Expiration Date: April 1, 2015

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-13-489-H01-P).

FOR NURSE PRACTITIONERS

This program is approved for 1.0 contact hour of continuing education (which includes 1.0 hour of pharmacology) by the American Association of Nurse Practitioners. Program ID 1401018. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

FOR NURSES

Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115. This program is approved for 1 hour of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Methods and Format

This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.

Target Audience

This continuing education activity was planned to meet the needs of pharmacists, nurses, nurse practitioners, and diabetes educators.

Activity Content

This educational activity will provide health care practitioners with an overview of treatment options for type 2 diabetes, focusing on new and existing incretin-based agents. The mechanism of action and role in therapy of existing and emerging options for the management of type 2 diabetes will be described, and the importance of considering patient-specific characteristics and preferences will be discussed.

Learning Objectives

At the conclusion of this knowledge-based continuing education activity, participants should be able to

Faculty

Curtis L. Triplitt, Pharm.D., CDE
Associate Director, Diabetes Research Center, Texas Diabetes Institute
Associate Professor, Department of Medicine, Division of Diabetes
University of Texas Health Science Center at San Antonio
San Antonio, Texas

View Bio

Curtis L. Triplitt, Pharm.D., CDE, is Associate Professor and Certified Diabetes Educator at the University of Texas Health Science Center at San Antonio (UTHSCSA) where he oversees many diabetes research projects. In addition, he clinically manages people with diabetes with an endocrinologist at the Texas Diabetes Institute.

Dr. Triplitt earned his Bachelor of Science degree in pharmacy from the University of Iowa and his Doctor of Pharmacy degree from the University of Texas at Austin and the Health Science Center at San Antonio. He completed a primary-care residency accredited by the American Society of Health-System Pharmacists at the William S. Middleton Veteran Administration’s Hospital in Madison, Wisconsin.

Dr. Triplitt is well respected as a clinician, researcher, and author. He is an investigator in several ongoing research studies related to diabetes, and he has published several book chapters on diabetes, as well as articles in peer-reviewed journals, including Diabetes Care, Diabetes Spectrum, Expert Review of Endocrinology & Metabolism, Pharmacotherapy, and Drugs. Dr. Triplitt is currently Secretary of the Texas Diabetes Council (TDC), which is legislatively mandated to develop and implement a state plan for diabetes treatment, education, and training. The TDC’s mission is also to develop standards of care for the prevention, identification, and treatment of patients with diabetes mellitus in Texas.

Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE
Director, Education Services
Mid-America Diabetes Associates
Wichita, Kansas

View Bio

Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE, is Director of Education Services at Mid-America Diabetes Associates. Ms. Hinnen provides clinical care and education to approximately 1,000 people with diabetes each year.

Ms. Hinnen has been a diabetes educator for over thirty years. She is involved extensively with the American Association of Diabetes Educators, having served as their national president. She was awarded their prestigious Distinguished Service Award and recently was honored with their fellow recognition. Ms. Hinnen has also served on the national board of directors for the American Diabetes Association and as an editor for Diabetes Spectrum. Her faculty positions are with the School of Pharmacy at the University of Kansas and with the Graduate Nursing Department and Physician Assistant Program at Wichita State University. Ms. Hinnen received fellow recognition from the American Academy of Nursing in 2003 and the American Association of Diabetes Educators in 2010.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty listed below report the following relationships pertinent to this activity:

Curtis L. Triplitt, Pharm.D., CDE
Dr. Triplitt serves on the speakers bureau for Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals and Eli Lilly, and Gilead.

Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE
Ms. Hinnen serves on the speakers bureau and as a consultant for Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb and Astra Zeneca LP, Eli Lilly, Pamlab, Roche, and Sanofi. She also serves as a consultant for Abbott and CeQur, and on the speakers bureau for Novo Nordisk.

The following planners report no relationships pertinent to this activity:

Kristi Hofer, Pharm.D.
Catherine Klein, B.S.Pharm.
Susan R. Dombrowski, M.S., B.S.Pharm.

ASHP staff has no relevant financial relationships to disclose.

Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaboration with Eli Lilly, and an independent medical education grant from Bristol-Myers Squibb and AstraZeneca LP.

Presentation

Launch Presentation (60 Minutes*)

*Allow additional time to complete the assessment and evaluation.

Download Assessment and Handout

Print the assessment (post-test) and handout of slides for your reference; however,your assessment must be submitted online.

Process CE

When you reach the end of the activity, follow instructions to complete the online process (i.e., take assessment test and complete evaluation) and obtain CE credit.

Additional Resources

For additional education and resources about this topic or to sign-up to be notified when new resources are available,visit www.leadingdiabetescare.org..